HuGE Literature Finder
Records 1-10
|
Alterations of mTOR signaling impact metabolic stress resistance in colorectal carcinomas with BRAF and KRAS mutations.
Scientific reports 2018 Jun 8 (1): 9204. Fritsche-Guenther Raphaela, Zasada Christin, Mastrobuoni Guido, Royla Nadine, Rainer Roman, Roßner Florian, Pietzke Matthias, Klipp Edda, Sers Christine, Kempa Stef |
|
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.
Cancer 2018 Jan . Ross Jeffrey S, Fakih Marwan, Ali Siraj M, Elvin Julia A, Schrock Alexa B, Suh James, Vergilio Jo-Anne, Ramkissoon Shakti, Severson Eric, Daniel Sugganth, Fabrizio David, Frampton Garrett, Sun James, Miller Vincent A, Stephens Philip J, Gay Laurie |
|
Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
British journal of cancer 2017 Jun 117 (1): 136-143. Chakrabarty Sanjiban, Varghese Vinay Koshy, Sahu Pranoy, Jayaram Pradyumna, Shivakumar Bhadravathi M, Pai Cannanore Ganesh, Satyamoorthy Kapaet |
|
Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection.
British journal of cancer 2016 May . Cacheux Wulfran, Rouleau Etienne, Briaux Adrien, Tsantoulis Petros, Mariani Pascale, Richard-Molard Marion, Buecher Bruno, Dangles-Marie Virginie, Richon Sophie, Lazartigues Julien, Jeannot Emmanuelle, Farkhondeh Fereshteh, Sastre-Garau Xavier, de La Rochefordière Anne, Labib Alain, Falcou Marie-Christine, Stevens Denise, Roth Arnaud, Roman-Roman Sergio, Mitry Emmanuel, Bièche Ivan, Lièvre Astr |
|
A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma.
Clinical colorectal cancer 2016 Mar . Bowles Daniel W, Kochenderfer Mark, Cohn Allen, Sideris Lucas, Nguyen Nghia, Cline-Burkhardt Vivian, Schnadig Ian, Choi Minsig, Nabell Lisle, Chaudhry Arvind, Ruxer Robert, Ucar Antonio, Hausman Diana, Walker Luke, Spira Alexander, Jimeno Anton |
|
Diet and colorectal cancer: analysis of a candidate pathway using SNPS, haplotypes, and multi-gene assessment.
Nutrition and cancer 2011 Nov 63 (8): 1226-34. Slattery Martha L, Lundgreen Abbie, Herrick Jennifer S, Caan Bette J, Potter John D, Wolff Roger |
|
Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Feb 29 (4_suppl): 628. Lee S J, Kim J G, Chae Y S, Kang B W, Jeon S W, Park J S, Park J Y, Choi G S, Lee Y |
|
Genetic variation in RPS6KA1, RPS6KA2, RPS6KB1, RPS6KB2, and PDK1 and risk of colon or rectal cancer.
Mutation research 2011 Jan 706 (1-2): 13-20. Slattery Martha L, Lundgreen Abbie, Herrick Jennifer S, Wolff Roger |
|
Genetic variation in a metabolic signaling pathway and colon and rectal cancer risk: mTOR, PTEN, STK11, RPKAA1, PRKAG2, TSC1, TSC2, PI3K and Akt1.
Carcinogenesis 2010 Sep 31 (9): 1604-11. Slattery Martha L, Herrick Jennifer S, Lundgreen Abbie, Fitzpatrick Francis A, Curtin Karen, Wolff Roger |
|
Clinical significance of genetic variations in the PI3K/PTEN/AKT/mTOR pathway in Korean patients with colorectal cancer.
Oncology 2010 79 (3-4): 278-82. Kim Jong Gwang, Chae Yee Soo, Sohn Sang Kyun, Kang Byung Woog, Moon Joon Ho, Lee Soo Jung, Jeon Seong Woo, Park Jun Seok, Park Jin Young, Choi Gyu Se |
- Page last reviewed:Mar 16, 2019
- Page last updated:Aug 05, 2020
- Content source: